I am kind of amazed that AEZS has only a 50 million dollar market cap. And they have 33 million in revenues. And a boat load of products and many in phase III. Compare to numerous other Bio Techs, This is the best one out there. Could easily justify a $10 stock price with this low market cap. The numbers are there. AEZS is Cheap!